Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 receptor antagonist ELN441958

被引:23
作者
Hawkinson, Jon E.
Szoke, Balazs G.
Garofalo, Albert W.
Hom, Dennis S.
Zhang, Hongbing
Dreyer, Mark
Fukuda, Juri Y.
Chen, Linda
Samant, Bhushan
Simmonds, Stellanie
Zeitz, Karla P.
Wadsworth, Angie
Liao, Anna
Chavez, Raymond A.
Zmolek, Wes
Ruslim, Lany
Bova, Michael P.
Holcomb, Ryan
Butelman, Eduardo R.
Ko, Mei-Chuan
Malmberg, Annika B.
机构
[1] Elan Pharmaceut, Lead Discovery & Optimizat, San Francisco, CA 94080 USA
[2] Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA
[3] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1124/jpet.107.120352
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The bradykinin B-1 receptor plays a critical role in chronic pain and inflammation, although efforts to demonstrate efficacy of receptor antagonists have been hampered by species-dependent potency differences, metabolic instability, and low oral exposure of current agents. The pharmacology, pharmacokinetics, and analgesic efficacy of the novel benzamide B-1 receptor antagonist 7-chloro-2-[3-(9-pyridin-4-yl-3,9-diazaspiro[ 5.5]undecanecarbonyl)phenyl]-2,3-dihydro-isoindol-1-one (ELN441958) is described. ELN441958 competitively inhibited the binding of the B-1 agonist ligand [3H]desArg(10-)kallidin ([3H]DAKD) to IMR-90 human fibroblast membranes with high affinity (K-i = 0.26 +/- 0.02 nM). ELN441958 potently antagonized DAKD ( but not bradykinin)-induced calcium mobilization in IMR-90 cells, indicating that it is highly selective for B-1 over B-2 receptors. Antagonism of agonist-induced calcium responses at B-1 receptors from different species indicated that ELN441958 is selective for primate over rodent B-1 receptors with a rank order potency (K-B, nanomolar) of human (0.12 +/- 0.02) similar to rhesus monkey (0.24 +/- 0.01) similar to rat (1.5 +/- 0.4) > mouse (14 +/- 4). ELN441958 had good permeability and metabolic stability in vitro consistent with high oral exposure and moderate plasma half-lives in rats and rhesus monkeys. Because ELN441958 is up to 120-fold more potent at primate than at rodent B1 receptors, it was evaluated in a primate pain model. ELN441958 dose-dependently reduced carrageenan-induced thermal hyperalgesia in a rhesus monkey tail-withdrawal model, with an ED50 similar to 3 mg/kg s.c. Naltrexone had no effect on the antihyperalgesia produced by ELN441958, indicating a lack of involvement of opioid receptors. ELN441958 is a novel small molecule bradykinin B-1 receptor antagonist exhibiting high oral bioavailability and potent systemic efficacy in rhesus monkey inflammatory pain.
引用
收藏
页码:619 / 630
页数:12
相关论文
共 43 条
[1]   Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys [J].
Bowen, CA ;
Fischer, BD ;
Mello, NK ;
Negus, SS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01) :264-273
[2]   Topical capsaicin-induced allodynia in unanesthetized primates: Pharmacological modulation [J].
Butelman, ER ;
Ball, JW ;
Harris, TJ ;
Kreek, MJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03) :1106-1114
[3]   The role of migrating leukocytes in IL-1β-induced up-regulation of kinin B1 receptors in rats [J].
Campos, MM ;
de Souza, GEP ;
Ricci, ND ;
Pesquero, JL ;
Teixeira, MM ;
Calixto, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) :1107-1114
[4]   Inhibition of acute nociceptive responses in rat spinal cord by a bradykinin B1 receptor antagonist [J].
Conley, RK ;
Wheeldon, A ;
Webb, JK ;
DiPardo, RM ;
Homnick, CF ;
Bock, MG ;
Chen, TB ;
Chang, RSL ;
Pettibone, DJ ;
Boyce, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 527 (1-3) :44-51
[5]   Drug transport to the brain:: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier [J].
Demeule, M ;
Régina, A ;
Jodoin, J ;
Laplante, A ;
Dagenais, C ;
Berthelet, F ;
Moghrabi, A ;
Béliveau, R .
VASCULAR PHARMACOLOGY, 2002, 38 (06) :339-348
[6]   Activation of kinin B1 receptors induces chemotaxis of human neutrophils [J].
Ehrenfeld, P. ;
Millan, C. ;
Matus, C. E. ;
Figueroa, J. E. ;
Burgos, R. A. ;
Nualart, F. ;
Bhoola, K. D. ;
Figueroa, C. D. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (01) :117-124
[7]   PLoS medicine - A medical journal for the Internet age [J].
Eisen, MB ;
Brown, PO ;
Varmus, HE .
PLOS MEDICINE, 2004, 1 (01) :2-3
[8]  
EMMERSON PJ, 1994, J PHARMACOL EXP THER, V271, P1630
[9]   Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics [J].
Evans, Christopher A. ;
Jolivette, Larry J. ;
Nagilla, Rakesh ;
Ward, Keith W. .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (07) :1255-1265
[10]   The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level [J].
Ferreira, J ;
Campos, MM ;
Araújo, R ;
Bader, M ;
Pesquero, JB ;
Calixto, JB .
NEUROPHARMACOLOGY, 2002, 43 (07) :1188-1197